Ghrelin stimulates proliferation of human osteoblastic TE85 cells via NO/cGMP signaling pathway

Deng-Hu Wang; Yun-Sheng Hu; Jun-Jie Du; Yun-Yu Hu; Wei-De Zhong; Wei-Jun Qin
February 2009
Endocrine (1355008X);Feb2009, Vol. 35 Issue 1, p112
Academic Journal
Abstract  Ghrelin regulates bone formation and osteoblast proliferation, but the detailed signaling pathway for its action on osteoblasts remains unclear. In human osteoblastic TE85 cells, we observed the effects and intracellular signaling pathway of ghrelin on cell proliferation using BrdU incorporation method. Ghrelin, at 10−10–10−8 M concentration, significantly increased BrdU incorporation into TE85 cells. The action of ghrelin was inhibited by d-Lys3-GHRP-6, a selective antagonist of GHS-R. Nitric oxide (NO) scavenger hemoglobin and the NO synthase inhibitor NAME eliminated the stimulatory action of ghrelin on proliferation, while NO donor SNAP and NO synthase substrate L-AME stimulated proliferation of osteoblastic TE85 cells. The cGMP analogue, 8-Br-cGMP, stimulated TE85 cell proliferation, and ghrelin did not enhance proliferation in the presence of 8-Br-cGMP. Inhibition of cGMP production by the guanylate cyclase inhibitor prevented ghrelin-induced osteoblastic TE85 cell proliferation. In conclusion, ghrelin stimulates proliferation of human osteoblastic TE85 cells via intracellular NO/cGMP signaling pathway.


Related Articles

  • ZNF580 mediates eNOS expression and endothelial cell migration/proliferation via the TGF-β1/ALK5/Smad2 pathway. Luo, Yuyu; Zhao, Ying; Li, Xiaodong; Zhao, Juan; Zhang, Wencheng // Molecular & Cellular Biochemistry;Aug2014, Vol. 393 Issue 1/2, p199 

    ZNF580 is a novel C2H2 zinc-finger nuclear transcription factor with potential involvement in the transforming growth factor-β1 (TGF-β1) signal transduction pathway. Emerging evidence suggests that TGF-β1 can regulate endothelial nitric oxide synthase (eNOS) expression in endothelial...

  • Cyclic Stretch Induces Inducible Nitric Oxide Synthase and Soluble Guanylate Cyclase in Pulmonary Artery Smooth Muscle Cells. Shah, Monica R.; Wedgwood, Stephen; Czech, Lyubov; Kim, Gina A.; Lakshminrusimha, Satyan; Schumacker, Paul T.; Steinhorn, Robin H.; Farrow, Kathryn N. // International Journal of Molecular Sciences;Feb2013, Vol. 14 Issue 2, p4334 

    In the pulmonary vasculature, mechanical forces such as cyclic stretch induce changes in vascular signaling, tone and remodeling. Nitric oxide is a potent regulator of soluble guanylate cyclase (sGC), which drives cGMP production, causing vasorelaxation. Pulmonary artery smooth muscle cells...

  • Solution structure of the extended neuronal nitric oxide synthase PDZ domain complexed with an associated peptide. Tochio, Hidehito; Zhang, Qiang; Mandal, Pravat; Li, Ming; Zhang, Mingjie // Nature Structural Biology;May99, Vol. 6 Issue 5, p417 

    The PDZ domain of neuronal nitric oxide synthase (nNOS) functions as a scaffold for organizing the signal transduction complex of the enzyme. The NMR structure of a complex composed of the nNOS PDZ domain and an associated peptide suggests that a two-stranded β-sheet C-terminal to the...

  • Efficient expression of human soluble guanylate cyclase in Escherichia coli and its signaling-related interaction with nitric oxide. Fangfang Zhong; Hongyan Wang; Tianlei Ying; Zhong-Xian Huang; Xiangshi Tan // Amino Acids;Jul2010, Vol. 39 Issue 2, p399 

    Soluble guanylate cyclase (sGC), as a nitric oxide (NO) sensor, is a critical heme-containing enzyme in NO-signaling pathway of eukaryotes. Human sGC is a heterodimeric hemoprotein, composed of a α-subunit (690 AA) and a heme-binding β-subunit (619 AA). Upon NO binding, sGC catalyzes the...

  • Nitric oxide inhibits ghrelin-induced cell proliferation and ERK1/2 activation in GH3 cells. Tian, Chunlei; Ye, Fei; Wang, Lei; Deng, Yuanguo; Dong, Yuanxun; Wang, Xiaodan; Xu, Tongjiang; Lei, Ting; Wang, Xiongwei // Endocrine (1355008X);Dec2010, Vol. 38 Issue 3, p412 

    Ghrelin stimulates growth hormone release and cell proliferation, which strongly supports a significant role for this peptide in the control of growth hormone-releasing adenomas function and growth. Nitric oxide can influence the stimulatory effects of ghrelin on growth hormone secretion in...

  • A Review of the Role of Sphingosine-1-Phosphate in the Brain: An Important Mediator Implicated in the Central Nervous System. PUNSAWAD, Chuchard // Walailak Journal of Science & Technology;2014, Vol. 11 Issue 5-8, p395 

    Sphingosine-1-phosphate (SIP) is a bioactive lipid that signals through a family of G proteincoupled receptors, consisting of 5 members, termed SI PI, S1P2, S1P3, S1P4 and S1P5. Activation of SIP results in the regulation of several cellular functions, including cell proliferation, process...

  • Role of sphingosine 1-phosphate in human pancreatic cancer cells proliferation and migration. Yun-Xia Guo; Ying-Jie Ma; Li Han; Yu-Jie Wang; Ji-Ao Han; Ying Zhu // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 11, p20349 

    Deregulation of production or degradation of sphingosine 1-phosphate (S1P), a bioactive lipid, involves in tumor progression, metastasis and chemoresistance. Since the tumor progression effects of S1P and its mechanism in human pancreatic cancer is not fully understood, we investigated the role...

  • Nitric Oxide: State of the Art in Drug Design. Serafim, R. A. M.; Primi, M. C.; Trossini, G. H. G.; Ferreira, E. I. // Current Medicinal Chemistry;Jan2012, Vol. 19 Issue 3, p386 

    Since the great discovery of Furchgott, Ignarro and Murad in the late 90's, nitric oxide (NO) is considered one of the most versatile endogenous molecules, which is involved in important signaling biochemistry pathways of the human body. Thus, it is directly related to pathological processes and...

  • Emerging role of PKA/eNOS pathway in therapeutic angiogenesis for ischaemic tissue diseases. Bir, Shyamal C.; Xiong, Yan; Kevil, Christopher G.; Luo, Jincai // Cardiovascular Research;Jul2012, Vol. 95 Issue 1, p7 

    Although an abundant amount of research has been devoted to the study of angiogenesis, its precise mechanisms are incompletely understood. Numerous clinical trials focused on therapeutic angiogenesis for the treatment of tissue ischaemia have not been as successful as those of preclinical...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics